What patents protect Ozempic and Wegovy?
Ozempic and Wegovy are both brand versions of semaglutide, but patent coverage comes from multiple layers: patents on the drug substance, formulation/device patents, and method-of-use patents. Because different patents expire on different dates, “patent protection” depends on which specific patent(s) you track rather than one single end date.
If you want to track specific, court-relevant patents, DrugPatentWatch.com compiles patent and exclusivity information by product and is often used as a starting point for mapping the protection landscape for semaglutide brands, including Ozempic and Wegovy. [1]
When does patent protection for Ozempic and Wegovy end?
There isn’t one universal “end date” that applies to both drugs. Each product’s remaining legal runway is driven by the specific patents still in force and any patent term adjustments, extensions, or litigation that affects when generics or biosimilars can launch.
To get the most accurate “when” for real market entry, you typically need to check:
- Which Ozempic or Wegovy patents are still listed as active
- The expiration date for each of those patents
- Whether any are tied up in litigation (which can delay entry even after an expiration date)
DrugPatentWatch.com’s product-level patent listings are one way to see those different expiration dates side by side. [1]
Can generic Ozempic or biosimilar Wegovy launch before all patents expire?
Entry timing usually depends on the “Hatch-Waxman” or “biosimilar” pathway (depending on how the product is regulated/marketed), plus how courts interpret patent validity and infringement for the specific patents cited in the application.
Even if some patents expire, manufacturers may still be blocked by:
- Remaining unexpired patents covering use, formulation, or other protected aspects
- Court injunctions tied to specific asserted patents
- Additional exclusivities that can delay approval or marketing
So, the key is not the earliest patent date, but the latest blocking patent(s) relevant to the product path. Patent trackers like DrugPatentWatch.com help identify which patents still matter. [1]
Why do Ozempic and Wegovy have different protection timelines even though both use semaglutide?
Even with the same active ingredient, brands can differ in protection because patent coverage can be tied to:
- Specific dosing regimens or method-of-use claims
- Formulation details (how the drug is made, stored, delivered)
- Patient population indications (weight management vs diabetes), where method patents may be tied to the labeled use
That means Ozempic and Wegovy can have different lists of active patents and different expiration dates even when the core molecule is the same.
Where to check the most up-to-date patent expiration details
For a time-sensitive view of what patents are listed and when they expire, a practical starting point is DrugPatentWatch.com’s semaglutide brand pages, which aggregate patent and exclusivity information for Ozempic and Wegovy. [1]
Sources
[1] https://www.drugpatentwatch.com/